Pei Jun Qu

Shanghai Jianguo Venture Capital Co., Ltd. engages in new technology venture capital investment and provision of enterprise management consultation, enterprise image planning, as well as financial consultation services. The company was founded on April 18, 2000 and is headquartered in Shanghai, China.

Part of Shanghai Origincell Biological Cryo Equipment Co. Ltd., Shanghai Xinchuan Investment Management Co. Ltd. provides investment and investment management services. The company is based in Shanghai, China. Shanghai Xinchuan Investment Management Co. was founded in 2011. Shanghai Xinchuan Investment Management Co. was acquired by Lishui Yuanxin Industry Development Co. Ltd. from Canature Health Technology Group Co., Ltd. on December 28, 2021 for $27.42 million.

The Origin Cell Technology Group Co., Ltd. is a Chinese company that engages in biotechnology development operation.

OriginCell Therapeutics (Shanghai) Co., Ltd. engages in the research and development of auto-immune cell technology. It offers collection, preparation, dispensing, and permanent storage services for autoimmune living cell. It also involves in the business of cancer treatment and rehabilitation medical services, apartments for the elderly, and business aircraft and helicopter operations management providing cell transport and emergency medical services. The company was founded by Jianguo Qu on February 4, 2015 and is headquartered in Shanghai, China.

Shanghai Fuyuan Pharmaceutical Co., Ltd. engages in the research and development of biotechnology; and the production and sale of biological products and pharmaceutical intermediates. It also sells hardware machinery, mechanical & electrical products, instrumentation, and chemical reagents. The company was founded on September 10, 2002 and is headquartered in Shanghai, China.